Clinical trial
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In…
NCT00359177 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00359177 |
|---|---|
| Title | Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment |
| Official title | An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Vomiting |
| Intervention type | Drug |
| Interventions | GW679769 |
| Enrollment | 24 |
| Start date | Dec 1, 2005 |
| Primary completion | Oct 12, 2006 |
| Completion | Oct 12, 2006 |
| First posted | Aug 1, 2006 |
| Last update posted | Sep 25, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: